Press Releases

Press Releases

Jun 11, 2020
Twist Bioscience Expands Offering of Synthetic SARS-CoV-2 RNA Controls
Jun 08, 2020
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 03, 2020
Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock
Jun 03, 2020
Twist Bioscience Announces Proposed Public Offering of Common Stock
Jun 01, 2020
Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection
May 26, 2020
Twist Bioscience to Present at the Jefferies Virtual Healthcare Conference
May 12, 2020
Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference
May 07, 2020
Twist Bioscience Reports Second Quarter Fiscal 2020 Financial Results
May 06, 2020
Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2
Apr 30, 2020
Twist Bioscience to Report Fiscal 2020 Second Quarter Financial Results on Thursday, May 7, 2020